Evidence map›Paper›PMID 26781332›Full record

Trial reportMolecular medicine reports2016

Treatment with the herbal medicine, naoxintong improves the protective effect of high-density lipoproteins on endothelial function in patients with type 2 diabetes.

Pu Lv, Xunliang Tong, Qing Peng, Yuanyuan Liu, Haiqiang Jin, Ran Liu, Wei Sun, Bing Pan, Lemin Zheng, Yining Huang

Open access · hybridAbstract readClinical Trial
In one paragraph

Trial report in Molecular medicine reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Pu LvDepartment of Neurology, Peking University First Hospital, Beijing 100034, P.R. China.
Xunliang TongDepartment of Neurology, Peking University First Hospital, Beijing 100034, P.R. China.
Qing PengDepartment of Neurology, Peking University First Hospital, Beijing 100034, P.R. China.
Yuanyuan LiuDepartment of Neurology, Peking University First Hospital, Beijing 100034, P.R. China.
Haiqiang JinDepartment of Neurology, Peking University First Hospital, Beijing 100034, P.R. China.
Ran LiuDepartment of Neurology, Peking University First Hospital, Beijing 100034, P.R. China.
Wei SunDepartment of Neurology, Peking University First Hospital, Beijing 100034, P.R. China.
Bing PanThe Institute of Cardiovascular Sciences and Institute of Systems Biomedicine, School of Basic Medical Sciences, and Key Laboratory of Molecular Cardiovascular Sciences, Ministry of Education, Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Ministry of Health, Peking University Health Science Center, Beijing 100191, P.R. China.
Lemin ZhengThe Institute of Cardiovascular Sciences and Institute of Systems Biomedicine, School of Basic Medical Sciences, and Key Laboratory of Molecular Cardiovascular Sciences, Ministry of Education, Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Ministry of Health, Peking University Health Science Center, Beijing 100191, P.R. China.
Yining HuangDepartment of Neurology, Peking University First Hospital, Beijing 100034, P.R. China.
Peking University · CNPeking University First Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The protective effect of high‑density lipoprotein (HDL) on endothelial function is impaired in patients with type 2 diabetes mellitus (T2DM), which may result in atherosclerotic complications. Naoxintong (NXT) is a compound preparation that includes Radix Astragali, Angelicae sinensis, Radix Paeoniae Rubra and Ligusticum wallichii. It is widely administered in China to prevent atherosclerotic complications. In the present study, NXT was administered to 69 patients with T2DM. HDLs were isolated from patient blood samples prior to and following the intervention. In vitro endothelial functions of HDL, including proliferation, migration, angiogenesis, and anti‑apoptosis were investigated by bromodeoxyuridine, wound healing, Transwell and Matrigel tube formation assays on human umbilical vein endothelial cells (HUVECs). The results from the present study demonstrated that HUVECs treated with HDL isolated from diabetic patients following NXT therapy exhibited increased proliferative effects (10‑27%; P<0.05), and improved migration ability (15‑35%; P<0.05), anti‑apoptotic function (23‑34%; P<0.05) and angiogenesis (30‑54%; P<0.001). Furthermore, the phosphorylation levels of Akt (26‑36%; P<0.01) and extracellular signal‑regulated kinase (16‑80%; P<0.01) were increased following NXT therapy. The present in vitro study demonstrates that the protective effect of HDL on endothelial function is markedly impaired in diabetic patients who tend to develop atherosclerosis, and the impaired function may be partly abrogated by NXT.

Indexed as

AdultAgedAged, 80 and overApoptosisCell MovementCell ProliferationDiabetes Mellitus, Type 2Drugs, Chinese HerbalEndothelial CellsEnzyme ActivationExtracellular Signal-Regulated MAP KinasesFemaleHerbal MedicineHumansHuman Umbilical Vein Endothelial CellsLipoproteins, HDLDrugs, Chinese HerbalExtracellular Signal-Regulated MAP KinasesLipoproteins, HDLnaoxintongProtective AgentsProto-Oncogene Proteins c-akt

Identifiers

PMID26781332
PMCPMC4768949
OpenAlexW2260840115

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.